SCHEMBL2230602

SCHEMBL2230602

CCCCOC(=O)/C=C/c1ccc(Oc2ccc([N+](=O)[O-])cn2)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.44
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HSPB1 P04792 1/20 0.43
KDM4E B2RXH2 2/20 0.43
TP53 P04637 1/20 0.43
PKM P14618 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
EGFR P00533 5/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2233135 0.85 ESR1 (0.48) APPESR1
SCHEMBL13582316 0.84 MAPT (0.50) MAPTALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL13582313 0.84 MAPT (0.50) MAPTALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL2230608 0.80 MAPT (0.44) MAPTALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL3134922 0.78 HSPB1 (0.53) MAPTALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL3134912 0.78 HSPB1 (0.53) MAPTALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL2232561 0.78 MAPT (0.47) MAPTALDH1A1SMN1; SMN2HSPB1KDM4E
SCHEMBL28368058 0.75 APP (0.52) MAPTALDH1A1SMN1; SMN2LMNATDP1
SCHEMBL27463292 0.75 APP (0.52) MAPTALDH1A1SMN1; SMN2LMNATDP1
SCHEMBL2230605 0.74 PPARG (0.43) MAPTALDH1A1SMN1; SMN2HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011093524-A1 DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-04 WO disclosed